You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ALDX Buy Disclosure
Brady Todd C · SEC Form 4 · Filed Jun 5, 2026
Buy
Calculated transaction value
$418.45K
Brady Todd C President And CEO
ALDX
Aldeyra Therapeutics
ALDX
Transaction date
Jun 3, 2026
Public filing date
Jun 5, 2026
Filing lag
Filed 2 days later
ALDX daily price context
Close on/before transaction
$1.86
Jun 3, 2026
First close after public filing
$1.74
Jun 8, 2026
30-day return after filing
+31.03%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 250,000 shares @ $1.67
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001193125-26-259637
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$418.45K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aldeyra Therapeutics, Inc. ALDX Current | Buy | Jun 3, 2026 | $418.45K |